You just read:

Vigilant Biosciences Announces Further Clinical Data in Support of its OncAlert® Oral Cancer Product Line at IFOS ENT World Congress 2017 Symposium and at Annual MASCC Meeting

News provided by

Vigilant Biosciences, Inc.

Jun 21, 2017, 08:00 ET